Excess Death Estimates in Patients with End-Stage Renal Disease - United States, February-August 2020
- PMID: 34081687
- PMCID: PMC8174675
- DOI: 10.15585/mmwr.mm7022e2
Excess Death Estimates in Patients with End-Stage Renal Disease - United States, February-August 2020
Abstract
End-stage renal disease (ESRD) is a condition in which kidney function has permanently declined such that renal replacement therapy* is required to sustain life (1). The mortality rate for patients with ESRD in the United States has been declining since 2001 (2). However, during the COVID-19 pandemic, ESRD patients are at high risk for COVID-19-associated morbidity and mortality, which is due, in part, to weakened immune systems and presence of multiple comorbidities (3-5). The ESRD National Coordinating Center (ESRD NCC) supports the Centers for Medicare & Medicaid Services (CMS) and the ESRD Networks†,§ through analysis of data, dissemination of best practices, and creation of educational materials. ESRD NCC analyzed deaths reported to the Consolidated Renal Operations in a Web-Enabled Network (CROWNWeb), a system that facilitates the collection of data and maintenance of information about ESRD patients on chronic dialysis or receiving a kidney transplant who are treated in Medicare-certified dialysis facilities and kidney transplant centers in the United States. Excess death estimates were obtained by comparing observed and predicted monthly numbers of deaths during February 1-August 31, 2020; predicted deaths were modeled based on data from January 1, 2016, through December 31, 2019. The analysis estimated 8.7-12.9 excess deaths per 1,000 ESRD patients, or a total of 6,953-10,316 excess deaths in a population of 798,611 ESRD patients during February 1-August 31, 2020. These findings suggest that deaths among ESRD patients during the early phase of the pandemic exceeded those that would have been expected based on previous years' data. Geographic and temporal patterns of excess mortality, including those among persons with ESRD, should be considered during planning and implementation of interventions, such as COVID-19 vaccination, infection control guidance, and patient education. These findings underscore the importance of data-driven technical assistance and further analyses of the causes and patterns of excess deaths in ESRD patients.
Conflict of interest statement
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Kelly M. Mayo is a current member of the National Forum of ESRD Networks Board of Directors. No other potential conflicts of interest were disclosed.
Figures
References
-
- Centers for Medicare & Medicaid Services. End-stage renal disease (ESRD). Baltimore, MD: US Department of Health and Human Services, Centers for Medicare & Medicaid Services; 2020. https://www.cms.gov/Medicare/Coordination-of-Benefits-and-Recovery/Coord...
-
- United States Renal Data System. USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, United States Renal Data System; 2019. https://usrds.org/media/2371/2019-executive-summary.pdf
-
- Division of Viral Diseases. Coronavirus diseases 2019 (COVID-19): interim SARS-CoV-2 testing guidelines for patients in outpatient hemodialysis facilities. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/dialysis/testing-patients....
-
- National Kidney Foundation. Kidney disease & COVID-19. New York, NY: National Kidney Foundation, Inc.; 2021. https://www.kidney.org/coronavirus/kidney-disease-covid-19
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
